Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · IEX Real-Time Price · USD
0.713
+0.071 (11.03%)
At close: May 2, 2024, 4:00 PM
0.712
-0.001 (-0.11%)
After-hours: May 2, 2024, 7:51 PM EDT

Biora Therapeutics Revenue

In the year 2023, Biora Therapeutics had annual revenue of $4.00K, a decrease of -98.69%.

Revenue (ttm)
$4.00K
Revenue Growth
-98.69%
P/S Ratio
6,394.49
Revenue / Employee
$69
Employees
58
Market Cap
25.58M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.00K-301.00K-98.69%
Dec 31, 2022305.00K-942.00K-75.54%
Dec 31, 20211.25M1.09M669.75%
Dec 31, 2020162.00K-143.82M-99.89%
Dec 31, 2019143.99M16.01M12.51%
Dec 31, 2018127.97M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Exagen 52.55M
Cumberland Pharmaceuticals 39.55M
Nephros 14.24M
Lumos Pharma 2.05M
Oncternal Therapeutics 785.00K
Bullfrog AI 65.00K
Lipocine -2.85M
Revenue Rankings